About the Company
ARYA Sciences Acquisition Corp III is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities.
Exchange
NASDAQ CAPITAL MARKET
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ARYA News
ARYA Sciences Acquisition Corp. III Class A
ChatGPT won't save the planet. Nor will Copilot, or Stability AI, or Claude. But there is still a sustainable promise to machine learning.
Arya Sciences Acquisition Corp IV - Ordinary Shares - Class A
ARYA Sciences Acquisition Corp. IV operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization ...
ARYA Sciences Secures Convertible Sponsor Loan
ARYA Sciences Acquisition Corp IV has secured a $1,000,000 unsecured convertible loan from its Sponsor to fund general ...
ARYA Sciences Acquisition Corp. IV Cl A
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
ARYA Sciences Acquisition Corp IV Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ARYA Sciences Acquisition Corp. IV Cl A
1 Day ARYD -0.09% DJIA -0.77% Russell 2K -1.27% Business/Consumer Services -0.28% ...
ARYA Sciences Acquisition Corp. IV Class A
ARYA Sciences Acquisition Corp. IV operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization ...
ARYA Sciences Acquisition Corp IV (ARYD)
Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, and ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) ("ARYA"), a ...
Loading the latest forecasts...